"Omega Pharma Baltics" SIAActive

40003440390Limited liability companyFounded 1999

Key figures

7 594 266 €+21,6%
Revenue 2024
+19,0%
Average annual growth 2011–2024
02 m4 m6 m8 m’11’12’13’14’15’16’17’18’19’20’21’22’23’24

Ratios

2024
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
01 m2 m3 m’11’12’13’14’15’16’17’18’19’20’21’22’23’24
Summary of financial statements2011–2024
20112012201320142015201620172018201920202021202220232024
Balance sheet — assets
Total current assets38 719219 800418 183542 454322 838143 996421 448727 906780 5701 145 1751 219 4542 408 4422 207 2642 858 804
Total non-current assets15 54233 95133 41334 52221 64242 32419847961135355327 25728 72316 7416354
Total assets54 261253 751451 596576 976344 480186 320423 432728 702781 7051 148 7281 246 7112 437 1652 224 0052 865 158
Balance sheet — liabilities and equity
Current liabilities90 340341 560521 036641 350434 07374 43545 417706 095614 067834 586525 9981 334 790767 986979 274
Non-current liabilities22760000000000000
Total liabilities92 616341 560521 036641 350434 07374 43545 417706 095614 067834 586525 9981 334 790767 986979 274
Share capital——————————————
Retained earnings of previous periods——————————————
Profit for the year-48 632-49 454-463228 343-58 84366 2685092131 616145 031146 504406 571381 662353 644429 865
Total equity-38 355-87 809-92 441-103 188-162 032-95 764-90 67222 607167 638314 142720 7131 102 3751 456 0191 885 884
Income statement
Sales revenue794 1691 254 5052 104 8982 975 0003 540 0003 597 6954 059 3844 610 5554 979 4155 029 9544 741 0296 742 6946 247 7127 594 266
Operating profit-48 456-49 329-459128 343-58 84353 16892 664134 281150 083146 504406 571381 662362 884438 444
Profit before income tax-48 734-49 454-463228 343-58 84353 16892 664134 281150 083146 504406 571381 662362 884438 444
Profit for the reporting year-48 632-49 454-463228 343-58 84366 2685092131 616145 031146 504406 571381 662353 644429 865
Labour costs——————————————
Depreciation of non-current assets——————————————
Other indicators
Employees1011111010131010101010151620
Calculated dividend00000000000000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph
100%"Omega Pharma Baltics…Omega Pharma GmbHAndrops RaimondsMunoz Royo Jorge
CompanyPersonShareholderOther roleAdditional link

Summary: "Omega Pharma Baltics" SIA

Overview

"Omega Pharma Baltics" SIA (reg. no. 40003440390) is a limited liability company. The company was registered in 1999 and has been in the register for 27 years. Registered address: Mārupes nov., Mārupe, Malduguņu iela 2.

Financial results

Revenue in 2024 was 7 594 266 €, up 21,6% on the previous year (6 247 712 €). From 2011 to 2024, revenue grew by an average of 19,0% per year. This is the company's highest revenue among the published years (2011–2024). Net profit for 2024 was 429 865 € (5,7% of revenue). The company was profitable in 10 of the 14 published years. In 2024 the company had 20 employees (16 a year earlier). Revenue per employee was 379 713 €. At the end of 2024, total assets were 2 865 158 € and equity 1 885 884 € (65,8% of assets).

Management and owners

The board has 2 members. The sole owner of the company is Omega Pharma GmbH.

Data sources and freshness

Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.